申请人:Eli Lilly and Company
公开号:US04996230A1
公开(公告)日:1991-02-26
This invention provides tricyclic derivatives which are leukotriene B.sub.4 antagonists, formulations of those derivatives, and a method of using those derivatives for the treatment of conditions characterized by an excessive release of leukotrienes.
这项发明提供了三环衍生物,它们是白三烯B.sub.4拮抗剂,还提供了这些衍生物的配方,以及使用这些衍生物治疗由白三烯过度释放引起的疾病的方法。